3046 Impact of bevacizumab in combination with erlotinib on EGFRmutatant non-small cell lung cancer xenograft models with T790M mutation or MET amplification. (September 2015) - Furugaki, K.; Fukumura, J.; Iwai, T.; Yorozu, K.; Yanagisawa, M.; Moriya, Y.; Kurasawa, M.; Yamamoto, K.; Suda, K.; Mizuuchi, H.; Mitsudomi, T.; Harada, N.